Skip to contentS
SI-BONE, Inc.
S
SIBNSI-BONE, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$56.35M$56.35Mderived+15.0% vs Q4 2024 Net Income-$1.64M-$1.64MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SI-BONE, Inc. · CIK 1459839 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$44,531,000+14.8% Operating Incomederived-$2,463,000N/M Operating Cash Flowderived$1,728,000+46.7% Free Cash Flowderived$440,000N/M Margins · derivedGross margin79.0%−0.1 pt vs Q4 2024
Operating margin-4.4%+6.8 pt vs Q4 2024
Net margin-2.9%+6.3 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 24, 2026 · 55 d after period end